Neuroendocrine Carcinoma of the Cervix Overview
Learn About Neuroendocrine Carcinoma of the Cervix
Regents Of The University Of California
Pratibha Binder is a Gynecologic Oncologist and an Oncologist in San Diego, California. Dr. Binder has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. Her top areas of expertise are Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Endometrial Cancer, Hysterectomy, and Salpingo-Oophorectomy.
Regents Of The University Of California
Michael Mchale is a Gynecologic Oncologist and an Oncologist in San Diego, California. Dr. Mchale and is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. His top areas of expertise are Endometrial Cancer, Cervical Cancer, Ovarian Cancer, Hysterectomy, and Salpingo-Oophorectomy.
Regents Of The University Of California
Ramez Eskander is a Gynecologic Oncologist and an Oncologist in San Diego, California. Dr. Eskander and is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Hysterectomy, and Splenectomy.
Summary: Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of SNS-101, a novel anti VISTA IgG1 monoclonal antibody as monotherapy or in combination with cemiplimab in patients with advanced solid tumors.
Summary: This study collects information and data on patients with neuroendocrine cervical cancer. Information from this study may be used to better understand the correlation between clinical data, such as patient characteristics, treatment, and disease outcomes, and overall patient outcomes.
Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center